182 related articles for article (PubMed ID: 17959940)
1. Intraoperative management of patients with carcinoid heart disease having valvular surgery: a review of one hundred consecutive cases.
Weingarten TN; Abel MD; Connolly HM; Schroeder DR; Schaff HV
Anesth Analg; 2007 Nov; 105(5):1192-9, table of contents. PubMed ID: 17959940
[TBL] [Abstract][Full Text] [Related]
2. Management of patients undergoing multivalvular surgery for carcinoid heart disease: the role of the anaesthetist.
Castillo JG; Filsoufi F; Adams DH; Raikhelkar J; Zaku B; Fischer GW
Br J Anaesth; 2008 Nov; 101(5):618-26. PubMed ID: 18689806
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of aprotinin use for reoperative valvular surgery.
Rodrigues AJ; Evora PR; Bassetto S; Luciano PM; Alves L; Filho AS; Vicente WV
Ann Thorac Surg; 2007 Jun; 83(6):2060-5. PubMed ID: 17532397
[TBL] [Abstract][Full Text] [Related]
4. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular abnormalities in patients with a carcinoid syndrome.
Meijer WC; van Veldhuisen DJ; Kema IP; Van den Berg MP; Boomsma F; Willemse PH; De Vries EG
Neth J Med; 2002 Mar; 60(1):10-6. PubMed ID: 12074037
[TBL] [Abstract][Full Text] [Related]
6. [Surgical treatment of carcinoid heart disease].
Watanabe T; Ohshima N; Shirai T; Someya T
Kyobu Geka; 2010 Oct; 63(11):999-1003. PubMed ID: 20954358
[TBL] [Abstract][Full Text] [Related]
7. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative Management of Carcinoid Heart Disease for Valvular Surgery.
Dalal A; Stone M
J Cardiothorac Vasc Anesth; 2016 Aug; 30(4):1046-9. PubMed ID: 26776749
[No Abstract] [Full Text] [Related]
9. [Carcinoid heart disease].
el-Rassi I; Oroudji M; Tapia M; Depoix JP; Henri I; Cormier B; Vissuzaine C; Acar C
Arch Mal Coeur Vaiss; 1998 Jan; 91(1):79-82. PubMed ID: 9749268
[TBL] [Abstract][Full Text] [Related]
10. Regression of metastatic carcinoid tumor after valvular surgery for carcinoid heart disease.
Rayson D; Pitot HC; Kvols LK
Cancer; 1997 Feb; 79(3):605-11. PubMed ID: 9028374
[TBL] [Abstract][Full Text] [Related]
11. The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass.
Manrique A; Jooste EH; Kuch BA; Lichtenstein SE; Morell V; Munoz R; Ellis D; Davis PJ
Anesth Analg; 2009 Jul; 109(1):45-52. PubMed ID: 19535694
[TBL] [Abstract][Full Text] [Related]
12. Carcinoid heart disease.
Bernheim AM; Connolly HM; Hobday TJ; Abel MD; Pellikka PA
Prog Cardiovasc Dis; 2007; 49(6):439-51. PubMed ID: 17498524
[TBL] [Abstract][Full Text] [Related]
13. Redo valvular surgery in elderly patients.
Maganti M; Rao V; Armstrong S; Feindel CM; Scully HE; David TE
Ann Thorac Surg; 2009 Feb; 87(2):521-5. PubMed ID: 19161771
[TBL] [Abstract][Full Text] [Related]
14. The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis.
Guzzetta NA; Evans FM; Rosenberg ES; Fazlollah TM; Baker MJ; Wilson EC; Kaiser AM; Tosone SR; Miller BE
Anesth Analg; 2009 Feb; 108(2):448-55. PubMed ID: 19151271
[TBL] [Abstract][Full Text] [Related]
15. Ascites, but not hyponatremia, is associated with high intraoperative transfusion and vasopressor requirements during liver transplantation.
Xia VW; Fond A; Du B
Transplant Proc; 2006 Jun; 38(5):1398-9. PubMed ID: 16797315
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of patients with carcinoid heart disease after valvular surgery.
Manoly I; McAnelly SL; Sriskandarajah S; McLaughlin KE
Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):302-5. PubMed ID: 24812331
[TBL] [Abstract][Full Text] [Related]
17. The critical role of aprotinin in controlling haemostasis in conjunction with non-pharmacological blood-saving strategies during routine coronary artery bypass surgery.
Khalil PN; Siebeck M; Ismail M; Khalil MN; von Knobelsdorff G; Marx G; Kalmar P
Eur J Med Res; 2006 Sep; 11(9):386-93. PubMed ID: 17101462
[TBL] [Abstract][Full Text] [Related]
18. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery.
Breuer T; Martin K; Wilhelm M; Wiesner G; Schreiber C; Hess J; Lange R; Tassani P
Eur J Cardiothorac Surg; 2009 Jan; 35(1):167-71; author reply 171. PubMed ID: 19027313
[TBL] [Abstract][Full Text] [Related]
19. Aprotinin in primary cardiac surgery: operative outcome of propensity score-matched study.
Ngaage DL; Cale AR; Cowen ME; Griffin S; Guvendik L
Ann Thorac Surg; 2008 Oct; 86(4):1195-202. PubMed ID: 18805159
[TBL] [Abstract][Full Text] [Related]
20. Independent predictors for early and long-term mortality after heart valve surgery.
Toumpoulis IK; Chamogeorgakis TP; Angouras DC; Swistel DG; Anagnostopoulos CE; Rokkas CK
J Heart Valve Dis; 2008 Sep; 17(5):548-56. PubMed ID: 18980089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
